Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes

PURPOSE: Metformin is the first-line antidiabetic drug and shown to reduce cardiovascular risk independent from its glucose lowering action. Particularly in poorly controlled diabetes, tissue factor (TF) is expressed in the vasculature and accounts for thromboembolic complications. Here, we aimed to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiovasc Drugs Ther
Autors principals: Witkowski, Marco, Friebel, Julian, Tabaraie, Termeh, Grabitz, Sinah, Dörner, Andrea, Taghipour, Lena, Jakobs, Kai, Stratmann, Bernd, Tschoepe, Diethelm, Landmesser, Ulf, Rauch, Ursula
Format: Artigo
Idioma:Inglês
Publicat: Springer US 2020
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8266708/
https://ncbi.nlm.nih.gov/pubmed/32940892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-020-07040-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars